NCT04146337View on ClinicalTrials.gov

Fecal Microbiota Transplantation for Carbapenem-resistant Enterobacteriaceae

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

October 12, 2020

Primary Completion Date

December 31, 2021

Study Completion Date

June 30, 2022

Conditions
Carbapenem-Resistant Enterobacteriaceae Infection
Interventions
BIOLOGICAL

FMT

Fecal microbiota in frozen capsules

Trial Locations (1)

Unknown

Rambam Health Care Campus, Haifa

All Listed Sponsors
lead

Rambam Health Care Campus

OTHER

NCT04146337 - Fecal Microbiota Transplantation for Carbapenem-resistant Enterobacteriaceae | Biotech Hunter | Biotech Hunter